FDA DEVICE FACTS
LINK MP Monoblock Hip Prosthesis
Waldemar Link GmbH & Co. KG
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The LINK® MP® Monoblock Hip Prosthesis is indicated for patients with Mobility-limiting diseases, fractures or defects of the hi p joint or proximal femur which cannot be treated by conservative or osteosynthetic procedures The LINK ® MP® Monoblock Hip Prosthesis is indicated for the following conditions: x Revision of loosened femoral prosthesis components involving extensive bone resorption of the proximal femur and widening of the medullary cavity or marked thinning of proximal femoral cortical bone the fixation of a new standard prosthesis is not possible x Revision of loosened femoral prosthesis components by peri- /subprosthetic fracture The device is intended for cementless use.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。